CLCA Inhibitors
CLCA inhibitors are chemical compounds that target and inhibit the function of members of the CLCA (calcium-activated chloride channel regulator) protein family. These proteins are involved in the regulation of calcium-activated chloride channels (CaCCs), which play a critical role in various physiological processes, including fluid secretion, ion transport, and smooth muscle contraction. CLCA proteins are not themselves ion channels but are known to modulate the activity of chloride channels by influencing their expression or function. Inhibition of CLCA proteins disrupts this regulation, leading to altered chloride ion flow across cell membranes, which can affect the movement of fluids and electrolytes in tissues where CLCA proteins are expressed, such as the respiratory, gastrointestinal, and cardiovascular systems.
The exact mechanism by which CLCA inhibitors exert their effects depends on how they interfere with the protein's regulatory role. They may bind to functional domains of the CLCA proteins, preventing their interaction with the chloride channels they regulate or inhibiting their expression at the cell surface. Since CLCA proteins are involved in complex signaling pathways that influence chloride channel activity, inhibitors of CLCA provide valuable tools for studying these regulatory mechanisms. By modulating CLCA activity, researchers can gain insights into the physiological functions of calcium-activated chloride channels and the broader processes of ion transport and epithelial function. Inhibition of CLCA proteins can also be used to explore how calcium signaling and chloride transport are interconnected in various tissues, contributing to the understanding of how these systems maintain fluid balance and cellular homeostasis.
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
5-Azacytidine can induce hypomethylation of DNA, potentially leading to the downregulation of CLCA gene expression if promoter methylation is a controlling factor for this gene. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A, by inhibiting histone deacetylase, could result in a more acetylated chromatin state, potentially leading to the repression of CLCA gene transcription due to changes in chromatin accessibility. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic Acid, through its inhibition of histone deacetylase, could promote histone hyperacetylation, which might repress transcriptional activity of the CLCA gene. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid can trigger differentiation and cell cycle arrest in certain cell types, which may include a reduction in CLCA expression as part of a broader alteration in gene expression profiles. | ||||||
Chetomin | 1403-36-7 | sc-202535 sc-202535A | 1 mg 5 mg | $186.00 $674.00 | 10 | |
Chetomin disrupts the function of hypoxia-inducible factor 1 (HIF-1), potentially leading to decreased CLCA expression under hypoxic conditions where HIF-1 is typically active. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin may exert its effect by downregulating the expression of genes involved in inflammation, which could include the CLCA gene if it is part of the inflammatory response. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin Gallate, the active component in green tea, may decrease the expression of genes related to inflammation and oxidative stress, potentially including CLCA, through its antioxidative properties. | ||||||
D,L-Sulforaphane | 4478-93-7 | sc-207495A sc-207495B sc-207495C sc-207495 sc-207495E sc-207495D | 5 mg 10 mg 25 mg 1 g 10 g 250 mg | $153.00 $292.00 $489.00 $1325.00 $8465.00 $933.00 | 22 | |
DL-Sulforaphane may activate the Nrf2 pathway, which can lead to a decrease in CLCA expression as part of a broader cellular response to oxidative stress. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol could inhibit the transcriptional activation of certain genes associated with inflammation and cell proliferation, potentially leading to decreased CLCA gene expression. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein, an isoflavone, may downregulate expression of genes involved in cell proliferation and survival, potentially encompassing the CLCA gene in certain cellular contexts. | ||||||